Michelson Prizes: Next Generation Grants
The Michelson Prizes: Next Generation Grants provide $150,000 in one-year funding to early-career scientists (≤ 35 years old) pursuing disruptive research in human immunology, vaccine discovery, and immunotherapy for major global diseases. Administered by the Michelson Medical Research Foundation in collaboration with Next Frontier Advisors, these grants aim to overcome critical roadblocks in vaccine development and deepen understanding of key immune processes.
Eligibility Criteria:
-
Researchers 35 years of age or under at the time of application.
-
Proposals must focus on human immunology and vaccine research.
-
Applicants from any related discipline—clinical research, biochemistry, molecular biology, protein engineering, computer science/AI, biophysics, nanotechnology, etc.—are welcome.
-
Prior track record of innovation and potential for high impact.
Funding Details:
-
Amount: $150,000 CAD per grant.
-
Duration: 1 year (January 1 – December 31, 2026).
-
Evaluation: Based on innovation, feasibility, and potential to transform vaccine discovery or immunotherapy.
Deadline:
-
Applications due June 22, 2025, 11:59 pm EDT (UTC –4).
-
Application portal opens April 1, 2025.
Where to Go for Further Information:
-
Apply & Details: Visit the Michelson Prizes portal (link available on Michelson Medical Research Foundation website).
-
Full Overview & Application Preview: Download from the Michelson Medical Research Foundation site.
-
Questions:
-
Review the online FAQs first.
-
For platform issues, use the “help” function in the sm.apply portal.
-
For eligibility or process questions, email: [email protected].
-
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023